Endothelium-derived relaxing factor (nitric oxide) has a tonic vasodilating action on coronary collateral vessels

Journal of the American College of Cardiology

Volumn 27, Issue 3, 1996, Pages 658-663

  Frank, Michael W ^a   Harris, Kathleen R ^a   Ahlin, Kalee A ^a   Klocke, Francis J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N(G) NITROARGININE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DILATATION; DOG; INTRACARDIAC DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0029921451     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00521-8     Document Type: Article

References (41)

1. Lefroy DC, Crake T, Uren NG, Davies GJ, Maseri A. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation 1993;88:43-54.
2. Ludmer PL, Selwyn AP, Shook TL. et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-51.
3. Chester AH, O'Neil GS, Moncada S, Tadjkarimi S, Yacoub MH. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet 1990;336:897-900.
4. Gage JE, Hess OM, Murakami T, Ritter M, Grimm J, Krayenbuehl HP. Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation 1986;73:865-76.
5. Gordon JB, Ganz P, Nabel EG, et al. Atherosclerosis and endothelial function influence the coronary response to exercise. J Clin Invest 1989;83: 1946-52.
6. Mudge GH, Grossman W, Mills RM, Lesch M, Braunwald E. Reflex increase in coronary vascular resistance in patients with ischemic heart disease. N Engl J Med 1976;295:1333-7.
7. Zeiher AM, Drexler H, Wollschlaeger H, Saurbier B, Just H. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol 1989;14:1181-90.
8. Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 1988;77:43-52.
9. Yeung AC, Vekshtein VI, Krantz DS, et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 1991;325:1551-6.
10. Luscher TF. Endothelium-derived relaxing and contracting factors: potential role in coronary artery disease. Eur Heart J 1989;10:847-57.
11. Selwyn AP, Yeung AC, Ryan TJ Jr, Raby K, Barry J, Ganz P. Pathophysiology of ischemia in patients with coronary artery disease. Prog Cardiovasc Dis 1992;35:27-39.
12. Vineberg A, Mahanti B, Litvak J. Experimental gradual coronary artery constriction by ameroid constrictors. Surgery 1960:47:765-71.
13. Fujita M, McKown DP, McKown MD, Franklin D. Opening of coronary collaterals by repeated brief coronary occlusions in conscious dogs. Angiology 1988;39:973-80.
14. Glenny RW, Bernard S, Brinkley M. Validation of fluorescent-labeled microspheres for measurement of regional organ perfusion. J Appl Physiol 1993;74:2585-97.
15. Chu A, Chambers DE, Lin C-C, et al. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. J Clin Invest 1991;87:1964-8.
16. Parent R, Pare R, Lavallec M. Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs. Am J Physiol 1992;262:H10-6.
17. Smith TP, Canty JM. Modulation of coronary autoregulatory responses by nitric oxide: evidence for flow-dependent resistance adjustments in conscious dogs. Circ Res 1993;73:232-40.
18. Komaru T, Lamping KG, Eastham CL, Harrison DG, Marcus ML, Dellsperger KC. Effect of an arginine analogue on acetylcholine-induced coronary microvascular dilation in dogs. Am J Physiol 1991;261(Heart Circ Physiol 30):H2001-7.
19. Tschudi M, Richard V, Buhler FR, Luschler TF. Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. Am J Physiol 1991;260:H13-20.
20. Schaper W, Sharma HS, Quinkler W, Markert T, Wunsch M, Schaper J. Molecular biologic concepts of coronary anastomoses. J Am Coll Cardiol 1990;15:513-8.
21. Scheel KW, Daulat G, Williams SE. Functional anatomical site of intramural collaterals in dogs. Am J Physiol 1990;259:H706-11.
22. Downey HF, Crystal GJ, Bashour FA. Functional significance of microvascular collateral anastomoses after chronic coronary artery occlusion. Microvasc Res 1981;21:212-22.
23. White FC, Bloor CM. Myocardial angiogenesis and vascular remolding induced by exercise training [abstract]. Circulation 1994;90 Suppl I:I-104.
24. White FC, Carroll SM, Magnet A, Bloor CM. Coronary collateral development in swine after coronary artery occlusion. Circ Res 1992;71:1490-500.
25. Unger EF, Banai S, Shou M, et al. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 1994;266:H1588-95.
26. Banai S, Jaklitsch MT, Shou M. et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994;89:2183-9.
27. Schaper W. Angiogenesis in the adult heart. Basic Res Cardiol 1991;86 Suppl 2:51-6.
28. Cohen MV. Coronary Collaterals: Clinical and Experimental Observations. Armonk (NY): Futura, 1985:34.
29. Wyatt D, Lee J, Downey JM. Determination of coronary collateral flow by a load line analysis. Circ Res 1982;50:663-70.
30. Altman J, Dulas D, Bache RJ. Effect of cyclooxygenase blockade on blood flow through well-developed coronary collateral vessels. Circ Res 1992;70: 1091-8.
31. Harrison DG, Chapman MP, Christy JP, Marcus ML. Studies of the functional site of the native coronary collaterals. Am J Physiol 1986;251: H1217-24.
32. Tillmanns H, Steinhausen M, Leinberger H, Thederan H, Kubler W. Pressure measurements in the terminal vascular bed of the epimyocardium of rats and cats. Circ Res 1981;49:1202-11.
33. Chilian WM, Eastman CL, Marcus ML. Microvascular distribution of the coronary vascular resistance in beating left ventricle. Am J Physiol 1986;251: H779-88.
34. Jones CJ, Kuo L, Davis MJ, DeFily DV, Chilian WM. Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand. Circulation 1995;91:1807-13.
35. Altman J, Dulas D, Pavek T, Laxson DD, Homans DC, Bache RJ. Endothelial function in well-developed canine coronary collateral vessels. Am J Physiol 1993;264(Heart Circ Physiol 33):H567-72.
36. Foreman B, Dai XZ, Homans DC, Laxson DD, Bache RJ. Effect of atrial natriuretic peptide on coronary collateral blood flow. Circ Res 1989;65: 1671-8.
37. Altman JD, Dulas D, Pavek T, Bache RJ. Effect of aspirin on coronary collateral blood flow. Circulation 1993;87:583-9.
38. Heavey DJ, Barrow SE, Hickling NE, Ritter JM. Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man. Nature 1985;318:186-8.
39. Kuo L, Chilian WM, Davis MJ. Interaction of pressure- and flow-induced responses in porcine coronary resistance vessels. Am J Physiol 1991; 261(Heart Circ Physiol 30):H1706-15.
40. G-nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res 1993;72:387-95.
41. Duncker DJ, Bache RJ. Inhibition of nitric oxide production aggravates myocardial hypo-perfusion during exercise in the presence of a coronary artery stenosis. Circ Res 1994;74:629-40.